On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

TopicLeading institutions, researchers & key papers

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis is a topic indexed in ScholarIQ from OpenAlex.

What is known about Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis?

ScholarIQrecord summary

This cluster of papers focuses on the diagnosis, management, and pathogenesis of idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease. It covers evidence-based guidelines, cellular and molecular mechanisms of fibrosis, therapeutic translation, treatment trials with drugs like pirfenidone and nintedanib, as well as the role of myofibroblasts and epithelial-mesenchymal transition in lung fibrosis.

How many works does Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis have?

ScholarIQindexed works

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis has 345 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis?

ScholarIQopenalex

The OpenAlex for Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis is on the source record.

What are the most-cited papers on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis?

ScholarIQmost cited works
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis: An Update of the 2011 Clinical Practice Guideline
Ganesh Raghu, Bram Rochwerg, Yuan Zhang, Carlos A. Cuello‐García, Arata Azuma, Juergen Behr, Jan Brożek, Harold R. Collard, William E. Cunningham, Sakae Homma, Takeshi Johkoh, Fernando J. Martínez, Jeffrey L. Myers, Shandra Protzko, Luca Richeldi, David M. Rind, Moisés Selman, Arthur C. Theodore, Athol U. Wells, Henk C. Hoogsteden, Holger J. Schünemann
American Journal of Respiratory and Critical Care Medicine. 20151,937 Citations
Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis
Arun C. Habermann, Austin J. Gutierrez, Linh T. Bui, Stephanie L. Yahn, Nichelle I. Winters, Carla L. Calvi, Lance Peter, Mei-I Chung, Chase J. Taylor, Christopher S. Jetter, Latha Raju, Jamie Roberson, Guixiao Ding, Lori Wood, Jennifer M. S. Sucre, Bradley W. Richmond, Ana Serezani, Wyatt J. McDonnell, Simon B. Mallal, Matthew J. Bacchetta, James E. Loyd, Ciara M. Shaver, Lorraine B. Ware, Ross M. Bremner, Rajat Walia, Timothy S. Blackwell, Nicholas E. Banovich, Jonathan A. Kropski
Science Advances. 20201,131 CitationsOPEN ACCESS
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features
Aryeh Fischer, Κατερίνα Αντωνίου, Kevin M. Brown, J. Cadranel, Tamera J. Corte, Roland M. du Bois, Joyce Lee, Kevin O. Leslie, David A. Lynch, Eric L. Matteson, Marta Mosca, Imre Noth, Luca Richeldi, Mary E. Strek, Jeffrey J. Swigris, Athol U. Wells, Sterling G. West, Harold R. Collard, Vincent Cottin
European Respiratory Journal. 20151,099 Citations
Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition
Jason R. Rock, Christina E. Barkauskas, Michael J. Cronce, Yan Xue, Jeffrey R. Harris, Jiurong Liang, Paul W. Noble, Brigid L.M. Hogan
Proceedings of the National Academy of Sciences. 20111,057 Citations
Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis
Julie A. Bjoraker, Jay H. Ryu, Mark Edwin, Jeffrey L. Myers, Henry D. Tazelaar, Darrell R. Schroeder, Kenneth P. Offord
American Journal of Respiratory and Critical Care Medicine. 19981,048 Citations

Where is Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis is open access?

ScholarIQopen access share
60%OPEN ACCESS
Gold
13%
Green
20%
Hybrid
0%
Bronze
27%
Closed
40%

Related on ScholarIQ

470M+ articles · 14-day free trial